Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: FDA approves BioMarin gene therapy for hemophilia A; former Pfizer worker charged with insider trading

    The FDA approved a BioMarin Pharmaceutical gene therapy for people with hemophilia A, an inherited and rare bleeding disorder.
    by Ed Silverman Jun 30, 2023 1 minute
    Source: Alex Hogan/STAT

    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect, , , and . And what about you? This is a fine time to enjoy the great outdoors — beaches, lakes, and woods are beckoning. You could take a drive in the country or stroll city streets. Perhaps this is an opportunity to connect with someone special. Or simply plan the rest of your life. Well, whatever you do, have a grand time. But be safe. And by the way, a holiday is coming up on this side of the pond, so we will take an extended break. Enjoy, and see you on Wednesday. …

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related Books & Audiobooks